Pharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insurance

Author： Högy Barbara  

Publisher： Springer Publishing Company

ISSN： 1618-7598

Source： The European Journal of Health Economics, Vol.9, Iss.2, 2008-05, pp. : 203-203

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment

By  

TRANSFUSION, Vol. 55, Iss. 5, 2015-05 ,pp. : 1067-1074

John Wiley & Sons Inc

Access to resources Recommend Favorite

Streptococcus pneumoniae antibody titres in patients with primary antibody deficiency receiving intravenous immunoglobulin (IVIG) compared to subcutaneous immunoglobulin (SCIG)

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 182, Iss. 1, 2015-10 ,pp. : 51-56

John Wiley & Sons Inc

Access to resources Recommend Favorite

Autoimmunity in Primary Antibody Deficiencies

By  

International Archives of Allergy and Immunology, Vol. 171, Iss. 3-4, 2016-12 ,pp. : 180-193

Karger

Access to resources Recommend Favorite

Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective

By  

Infection Control & Hospital Epidemiology, Vol. 38, Iss. 8, 2017-06 ,pp. : 906-911

Cambridge University Press

Access to resources Recommend Favorite

The cost-effectiveness of solifenacin vs. trospium in the treatment of patients with overactive bladder in the German National Health Service

By Nazir J.   Hart W.M.  

Journal of Medical Economics, Vol. 17, Iss. 6, 2014-06 ,pp. : 408-414

Informa Healthcare

Access to resources Recommend Favorite